Trials / Unknown
UnknownNCT02653339
Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a controlled clinical trials about traditional Chinese medicine named Qufeng Shengshi Fang,which consisted of cicada slough,bombyx batryticatus,radix angelicae,radix sileris,honeysuckle flower,forsythia,lithospermum and radix glycyrrhizae,and Loratadine on treatment of Allergic Rhinitis.There are 180 Patients with allergic rhinitis recruited from Department of Allergy and Traditional Chinese.To carry on statistical analysis of the result of the self and between-group cross-reference by two questionnaires filled before and after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Qufeng Shengshi Fang and Loratadine | The patients with allergic rhinitis are divided into two groups, one is experimental group, and the other is control group. The experimental group patients are treated with Qufeng by oral, 200ml two times a day and Loratadine by oral,10mg QD |
| DRUG | Loratadine | The patients with allergic rhinitis are divided into two groups, one is experimental group, and the other is control group. The control group patients are treated with Loratadine by oral, 10mg QD |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-03-01
- Completion
- 2018-08-01
- First posted
- 2016-01-12
- Last updated
- 2016-04-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02653339. Inclusion in this directory is not an endorsement.